心臓組織工学の世界市場レポート 2025年

心臓組織工学市場規模は、今後数年で急成長が見込まれます。2029年には16億4,000万米ドルに成長し、CAGRは19.4%に達します。予測期間における成長の原動力は、個別化心臓治療に対する需要の増加、バイオエンジニアリングされた心臓組織への注目の高まり、再生医療アプリケーションの拡大、バイオテクノロジー企業とアカデミアのコラボレーションの拡大、前臨床試験プラットフォームへの投資の増加、慢性心疾患の有病率の上昇です。主な動向には、組織工学におけるAIの統合、ナノテクノロジーに基づく足場の発展、生分解性ハイドロゲルの開発、3Dバイオプリンティング精度の進歩、組織成熟のためのバイオリアクターの使用、心臓細胞強化のための遺伝子編集などがあります。

心血管疾患の有病率の増加は、心臓組織工学市場の成長を促進すると予想されます。心臓組織工学は、損傷した心臓組織を修復、再生、置換するための生物学的または生物学的人工構築物の作成を専門とする学際的分野です。心血管疾患の増加は、食生活の乱れ、運動不足、喫煙、肥満や糖尿病率の上昇など、不健康なライフスタイルの選択に大きく起因しています。心臓組織工学は、損傷した心筋を修復・再生し、心機能を回復させるために、生体材料、細胞ベースの治療法、生体工学組織を利用することによって、心血管疾患に対処します。例えば、2023年5月、米国の政府機関である疾病管理予防センターは、18歳以上の女性成人の冠動脈性心疾患の有病率が2022年の3.6％から2023年には3.7％にわずかに増加したと報告しました。その結果、心血管疾患の罹患率の上昇が心臓組織工学市場の拡大に拍車をかけています。

心臓組織工学市場の主要企業は、心血管疾患治療のための創薬の精度と効率を向上させるため、3D人工筋肉組織などの技術的進歩に注力しています。3D人工筋肉組織は、ヒトの筋肉の構造的・機能的特性を模倣した生体工学的構築物であり、主に薬剤試験や疾患モデリングに使用されます。例えば、2022年7月、米国のバイオテクノロジー企業であるCuri Bio Inc.は、ヒトに関連した3D心臓および骨格人工筋肉組織（EMT）の収縮力を分析するためのMantarrayプラットフォームを発表しました。このプラットフォームは、高度な組織培養技術を活用して、天然筋の力学的特性や挙動を再現した高機能筋組織を作製し、薬剤試験により精密なモデルを提供します。この技術は、研究者が細胞レベルで筋収縮、刺激に対する反応、および疾患モデリングを研究できるようにすることで、治療ソリューションの開発を強化します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界心臓組織工学 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の心臓組織工学市場：成長率分析
• 世界の心臓組織工学市場の実績：規模と成長, 2019-2024
• 世界の心臓組織工学市場の予測：規模と成長, 2024-2029, 2034F
• 世界心臓組織工学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心臓組織工学市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓弁
• 血管移植
• 世界の心臓組織工学市場：素材別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 幹細胞
• 足場
• 世界の心臓組織工学市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心筋梗塞
• 心臓弁の修復または置換
• 先天性心疾患の治療
• その他の用途
• 世界の心臓組織工学市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 学術研究機関
• その他のエンドユーザー
• 世界の心臓組織工学市場心臓弁の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生体心臓弁
• 人工心臓弁
• 組織工学による心臓弁
• 世界の心臓組織工学市場血管移植片の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成血管移植
• 生物学的血管移植
• 組織工学による血管移植

第7章 地域別・国別分析

• 世界の心臓組織工学市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の心臓組織工学市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心臓組織工学市場：競合情勢
• 心臓組織工学市場：企業プロファイル
  • Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Artivion Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Tissue Regenix Group plc Overview, Products and Services, Strategy and Financial Analysis
  • PromoCell GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Xeltis AG
• Carmat S.A.
• Bioheart Inc.
• Prellis Biologics Inc.
• Cytograft Tissue Engineering Inc.
• Avery Therapeutics Inc.
• Vascudyne Inc.
• Auto Tissue Berlin GmbH
• CorMatrix Cardiovascular Inc.
• Humacyte Inc.
• BioCardia Inc.
• Osiris Therapeutics Inc.
• StemCells Inc.
• ViroMed Co. Ltd.
• Cardio3 Biosciences

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 心臓組織工学市場2029：新たな機会を提供する国
• 心臓組織工学市場2029：新たな機会を提供するセグメント
• 心臓組織工学市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cardiac tissue engineering involves advanced biomedical techniques to develop functional heart tissue for repairing or regenerating damaged heart muscles. This field integrates cells, biomaterials, and bioactive factors to create engineered tissues that restore cardiac function and support heart disease treatment.

The primary products in cardiac tissue engineering include heart valves and vascular grafts. Heart valves regulate blood flow within the heart, ensuring proper circulation. The key materials used are stem cells and scaffolds. Applications range from myocardial infarction treatment and heart valve repair or replacement to congenital heart disease management and more. These technologies are utilized by hospitals and clinics, academic and research institutes, and other healthcare providers.

The cardiac tissue engineering market research report is one of a series of new reports from The Business Research Company that provides cardiac tissue engineering market statistics, including cardiac tissue engineering industry global market size, regional shares, competitors with a cardiac tissue engineering market share, detailed cardiac tissue engineering market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac tissue engineering industry. This cardiac tissue engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac tissue engineering market size has grown rapidly in recent years. It will grow from $0.67 billion in 2024 to $0.81 billion in 2025 at a compound annual growth rate (CAGR) of 19.7%. The growth during the historic period was driven by organ donor shortages, the increasing prevalence of cardiovascular diseases, innovations in biomaterials, rising investment in regenerative medicine, demand for personalized medicine, advancements in bioreactor systems, increasing government funding for biomedical research, and a growing focus on minimally invasive therapies.

The cardiac tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $1.64 billion in 2029 at a compound annual growth rate (CAGR) of 19.4%. The projected growth in the forecast period is driven by increasing demand for personalized cardiac therapies, a rising focus on bioengineered heart tissues, the expansion of regenerative medicine applications, growing collaborations between biotech firms and academia, increased investment in preclinical testing platforms, and the rising prevalence of chronic heart diseases. Key trends include the integration of AI in tissue engineering, advancements in nanotechnology-based scaffolds, the development of biodegradable hydrogels, progress in 3D bioprinting precision, the use of bioreactors for tissue maturation, and gene editing for cardiac cell enhancement.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the cardiac tissue engineering market. Cardiac tissue engineering is an interdisciplinary field dedicated to creating biological or bioartificial constructs to repair, regenerate, or replace damaged heart tissue. The rise in cardiovascular diseases is largely attributed to unhealthy lifestyle choices, including poor diet, physical inactivity, smoking, and rising obesity and diabetes rates. Cardiac tissue engineering addresses cardiovascular diseases by utilizing biomaterials, cell-based therapies, and bioengineered tissues to repair or regenerate damaged heart muscle and restore cardiac function. For example, in May 2023, the Centers for Disease Control and Prevention, a US-based governmental organization, reported that the prevalence of coronary heart disease among female adults aged 18 and over slightly increased to 3.7% in 2023 from 3.6% in 2022. Consequently, the rising incidence of cardiovascular diseases is fueling the expansion of the cardiac tissue engineering market.

Leading companies in the cardiac tissue engineering market are focusing on technological advancements, such as 3D-engineered muscle tissues, to improve the accuracy and efficiency of drug discovery for cardiovascular disease treatments. 3D-engineered muscle tissues are bioengineered constructs that mimic the structural and functional properties of human muscle, primarily used for drug testing and disease modeling. For instance, in July 2022, Curi Bio Inc., a US-based biotechnology company, introduced the Mantarray platform for analyzing contractility in human-relevant 3D heart and skeletal engineered muscle tissue (EMT). This platform leverages advanced tissue culture techniques to generate highly functional muscle tissues that replicate the mechanical properties and behavior of natural muscle, providing a more precise model for drug testing. The technology enhances the development of therapeutic solutions by enabling researchers to study muscle contraction, responses to stimuli, and disease modeling at a cellular level.

In April 2024, Valo Health LLC, a US-based technology company, acquired TARA Biosystems Inc. for an undisclosed amount. Through this acquisition, Valo Health aims to leverage TARA's proprietary human cardiac disease platform to advance the discovery of new medicines for cardiovascular diseases. TARA Biosystems Inc. is a US-based company specializing in the development of 3D-engineered cardiac tissue models for drug discovery and disease modeling.

Major players in the cardiac tissue engineering market are Biotronik SE & Co. KG, Terumo Corporation, Artivion Inc., Tissue Regenix Group plc, PromoCell GmbH, Xeltis AG, Carmat S.A., Bioheart Inc., Prellis Biologics Inc., Cytograft Tissue Engineering Inc., Avery Therapeutics Inc., Vascudyne Inc., Auto Tissue Berlin GmbH, CorMatrix Cardiovascular Inc., Humacyte Inc., BioCardia Inc., Osiris Therapeutics Inc., StemCells Inc., ViroMed Co. Ltd., Cardio3 Biosciences.

North America was the largest region in the cardiac tissue engineering market in 2024. The regions covered in cardiac tissue engineering report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cardiac tissue engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac tissue engineering market consists of revenues earned by entities by providing services such as the development of stem cell therapy and regeneration services, tissue engineering consultation and research services, and bioreactor and biomanufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac tissue engineering market includes sales of bioengineered cardiac tissues, biomaterials, cardiac tissue constructs, tissue scaffolds, bioactive molecules, and bioreactors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Tissue Engineering Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac tissue engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac tissue engineering ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac tissue engineering market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Heart Valves, Vascular Grafts
• 2) By Material: Stem Cells, Scaffolds
• 3) By Application: Myocardial Infarction, Heart Valve Repair Or Replacement, Congenital Heart Disease Treatment, Other Applications
• 4) By End Users: Hospitals And Clinics, Academic And Research Institutes, Other End Users
• Subsegments:
• 1) By Heart Valves: Bioprosthetic Heart Valves; Mechanical Heart Valves; Tissue-Engineered Heart Valves
• 2) By Vascular Grafts: Synthetic Vascular Grafts; Biologic Vascular Grafts; Tissue-Engineered Vascular Grafts
• Companies Mentioned: Biotronik SE & Co. KG; Terumo Corporation; Artivion Inc.; Tissue Regenix Group plc; PromoCell GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Tissue Engineering Market Characteristics

3. Cardiac Tissue Engineering Market Trends And Strategies

4. Cardiac Tissue Engineering Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cardiac Tissue Engineering Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiac Tissue Engineering PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiac Tissue Engineering Market Growth Rate Analysis
• 5.4. Global Cardiac Tissue Engineering Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiac Tissue Engineering Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiac Tissue Engineering Total Addressable Market (TAM)

6. Cardiac Tissue Engineering Market Segmentation

• 6.1. Global Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Heart Valves
• Vascular Grafts
• 6.2. Global Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cells
• Scaffolds
• 6.3. Global Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Myocardial Infarction
• Heart Valve Repair Or Replacement
• Congenital Heart Disease Treatment
• Other Applications
• 6.4. Global Cardiac Tissue Engineering Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Academic And Research Institutes
• Other End Users
• 6.5. Global Cardiac Tissue Engineering Market, Sub-Segmentation Of Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioprosthetic Heart Valves
• Mechanical Heart Valves
• Tissue-Engineered Heart Valves
• 6.6. Global Cardiac Tissue Engineering Market, Sub-Segmentation Of Vascular Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Vascular Grafts
• Biologic Vascular Grafts
• Tissue-Engineered Vascular Grafts

7. Cardiac Tissue Engineering Market Regional And Country Analysis

• 7.1. Global Cardiac Tissue Engineering Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiac Tissue Engineering Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Tissue Engineering Market

• 8.1. Asia-Pacific Cardiac Tissue Engineering Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Tissue Engineering Market

• 9.1. China Cardiac Tissue Engineering Market Overview
• 9.2. China Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Tissue Engineering Market

• 10.1. India Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Tissue Engineering Market

• 11.1. Japan Cardiac Tissue Engineering Market Overview
• 11.2. Japan Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Tissue Engineering Market

• 12.1. Australia Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Tissue Engineering Market

• 13.1. Indonesia Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Tissue Engineering Market

• 14.1. South Korea Cardiac Tissue Engineering Market Overview
• 14.2. South Korea Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Tissue Engineering Market

• 15.1. Western Europe Cardiac Tissue Engineering Market Overview
• 15.2. Western Europe Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Tissue Engineering Market

• 16.1. UK Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Tissue Engineering Market

• 17.1. Germany Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Tissue Engineering Market

• 18.1. France Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Tissue Engineering Market

• 19.1. Italy Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Tissue Engineering Market

• 20.1. Spain Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Tissue Engineering Market

• 21.1. Eastern Europe Cardiac Tissue Engineering Market Overview
• 21.2. Eastern Europe Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Tissue Engineering Market

• 22.1. Russia Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Tissue Engineering Market

• 23.1. North America Cardiac Tissue Engineering Market Overview
• 23.2. North America Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Tissue Engineering Market

• 24.1. USA Cardiac Tissue Engineering Market Overview
• 24.2. USA Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Tissue Engineering Market

• 25.1. Canada Cardiac Tissue Engineering Market Overview
• 25.2. Canada Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Tissue Engineering Market

• 26.1. South America Cardiac Tissue Engineering Market Overview
• 26.2. South America Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Tissue Engineering Market

• 27.1. Brazil Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Tissue Engineering Market

• 28.1. Middle East Cardiac Tissue Engineering Market Overview
• 28.2. Middle East Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Tissue Engineering Market

• 29.1. Africa Cardiac Tissue Engineering Market Overview
• 29.2. Africa Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Tissue Engineering Market Competitive Landscape And Company Profiles

• 30.1. Cardiac Tissue Engineering Market Competitive Landscape
• 30.2. Cardiac Tissue Engineering Market Company Profiles
  • 30.2.1. Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Artivion Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Tissue Regenix Group plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PromoCell GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Tissue Engineering Market Other Major And Innovative Companies

• 31.1. Xeltis AG
• 31.2. Carmat S.A.
• 31.3. Bioheart Inc.
• 31.4. Prellis Biologics Inc.
• 31.5. Cytograft Tissue Engineering Inc.
• 31.6. Avery Therapeutics Inc.
• 31.7. Vascudyne Inc.
• 31.8. Auto Tissue Berlin GmbH
• 31.9. CorMatrix Cardiovascular Inc.
• 31.10. Humacyte Inc.
• 31.11. BioCardia Inc.
• 31.12. Osiris Therapeutics Inc.
• 31.13. StemCells Inc.
• 31.14. ViroMed Co. Ltd.
• 31.15. Cardio3 Biosciences

32. Global Cardiac Tissue Engineering Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Tissue Engineering Market

34. Recent Developments In The Cardiac Tissue Engineering Market

35. Cardiac Tissue Engineering Market High Potential Countries, Segments and Strategies

• 35.1 Cardiac Tissue Engineering Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiac Tissue Engineering Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiac Tissue Engineering Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer